Eli Lilly (NYSE:LLY) recently experienced a slight decline in share price of 1.38% over the last month. This period coincided ...

Eli Lilly and Company (NYSE:LLY) will participate in the Bank of America Securities 2025 Healthcare Conference, May 15, 2025.

Cigna (CI) unveils ENGUIDE, a specialized GLP-1 pharmacy to be launched next month as demand for obesity drugs like Wegovy ...

Investing.com -- Novo Nordisk (NYSE: NVO) shares climbed 5.4% Friday after the U.S. Food and Drug Administration accepted the ...

Danish drugmaker Novo Nordisk (NOV: N) has secured a significant advantage in the high-stakes obesity drug market after ...

Q1 2025 Earnings Call Transcript April 30, 2025 Operator: Good afternoon, thank you for attending today’s Teladoc Health ...

Amazon talks up AI potential on earnings call, points to limited tariff impact. American Airlines commits to $4 billion ...

FTSE 100, Dow Jones Industrial Average, Euro Stoxx 50, Nikkei 225. Read 's Market Analysis on Investing.com ZA.

Eli Lilly's Zepbound loses CVS coverage to Wegovy, prompting analyst debate on pricing pressures and long-term obesity market ...

With Wegovy in its portfolio, Novo Nordisk is a very good bet to continue being a winner. As it's currently considered something of an underdog, with its stock priced accordingly, it's also trading at ...